Paul L. Berns sold Neumora Therapeutics ($NMRA) shares once on the open market in the last year, totaling $34,459, with the latest sale on February 17, 2026. This ranks him 10,704th among 11,678 insiders by sale value, well below the average of $8.6 million across about 6.4 transactions per insider. He made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 17, 2026 | Neumora Therapeutics, Inc. | $NMRA | BERNS PAUL L | See Remarks | S | Common Stock | 9819 | $3.51 | 7,794,476.0000 | 167,089,114 | 0.13% | 0.01% |
| Jan. 8, 2026 | Neumora Therapeutics, Inc. | $NMRA | BERNS PAUL L | See Remarks | A | Stock Option (Right to Buy) | 1650000 | $0.00 | 1,650,000.0000 | 167,089,114 | 9999.99% | 0.99% |
| Nov. 13, 2025 | Metsera, Inc. | $MTSR | BERNS PAUL L | Not found | D | Stock Option (right to buy) | 24188 | $0.00 | 0.0000 | 105,376,189 | 100.00% | 0.02% |
| Nov. 13, 2025 | Metsera, Inc. | $MTSR | BERNS PAUL L | Not found | A | Restricted Stock Unit | 4031 | $0.00 | 4,031.0000 | 105,376,189 | 9999.99% | 0.00% |
| Nov. 13, 2025 | Metsera, Inc. | $MTSR | BERNS PAUL L | Not found | D | Common Stock | 957559 | $0.00 | 0.0000 | 105,376,189 | 100.00% | 0.91% |
| Nov. 13, 2025 | Metsera, Inc. | $MTSR | BERNS PAUL L | Not found | D | Common Stock | 8313680 | $0.00 | 0.0000 | 105,376,189 | 100.00% | 7.89% |
| Nov. 13, 2025 | Metsera, Inc. | $MTSR | BERNS PAUL L | Not found | D | Common Stock | 7523682 | $0.00 | 0.0000 | 105,376,189 | 100.00% | 7.14% |
| Nov. 13, 2025 | Metsera, Inc. | $MTSR | BERNS PAUL L | Not found | D | Common Stock | 4031 | $0.00 | 0.0000 | 105,376,189 | 100.00% | 0.00% |
| Nov. 13, 2025 | Metsera, Inc. | $MTSR | BERNS PAUL L | Not found | D | Stock Option (right to buy) | 223430 | $0.00 | 0.0000 | 105,376,189 | 100.00% | 0.21% |
| May 28, 2025 | Neumora Therapeutics, Inc. | $NMRA | BERNS PAUL L | See Remarks | D | Stock Option (Right to Buy) | 497049 | $0.00 | 0.0000 | 161,978,923 | 100.00% | 0.31% |
| May 28, 2025 | Neumora Therapeutics, Inc. | $NMRA | BERNS PAUL L | See Remarks | D | Stock Option (Right to Buy) | 955864 | $0.00 | 0.0000 | 161,978,923 | 100.00% | 0.59% |
| May 28, 2025 | Neumora Therapeutics, Inc. | $NMRA | BERNS PAUL L | See Remarks | D | Stock Option (Right to Buy) | 342500 | $0.00 | 0.0000 | 161,978,923 | 100.00% | 0.21% |
| May 28, 2025 | Neumora Therapeutics, Inc. | $NMRA | BERNS PAUL L | See Remarks | D | Stock Option (Right to Buy) | 2000000 | $0.00 | 0.0000 | 161,978,923 | 100.00% | 1.23% |
| May 28, 2025 | Neumora Therapeutics, Inc. | $NMRA | BERNS PAUL L | See Remarks | A | Stock Option (Right to Buy) | 497049 | $0.00 | 497,049.0000 | 161,978,923 | 9999.99% | 0.31% |
| May 28, 2025 | Neumora Therapeutics, Inc. | $NMRA | BERNS PAUL L | See Remarks | A | Stock Option (Right to Buy) | 955864 | $0.00 | 955,864.0000 | 161,978,923 | 9999.99% | 0.59% |
| May 28, 2025 | Neumora Therapeutics, Inc. | $NMRA | BERNS PAUL L | See Remarks | A | Stock Option (Right to Buy) | 342500 | $0.00 | 342,500.0000 | 161,978,923 | 9999.99% | 0.21% |
| May 28, 2025 | Neumora Therapeutics, Inc. | $NMRA | BERNS PAUL L | See Remarks | A | Stock Option (Right to Buy) | 2000000 | $0.00 | 2,000,000.0000 | 161,978,923 | 9999.99% | 1.23% |
| May 20, 2025 | Metsera, Inc. | $MTSR | BERNS PAUL L | Not found | A | Stock Option (Right to Buy) | 24188 | $0.00 | 24,188.0000 | 105,050,219 | 9999.99% | 0.02% |
| Feb. 18, 2025 | Neumora Therapeutics, Inc. | $NMRA | BERNS PAUL L | See Remarks | S | Common Stock | 13871 | $1.69 | 7,804,295.0000 | 0 | 0.18% | 0.00% |
| Feb. 13, 2025 | Neumora Therapeutics, Inc. | $NMRA | BERNS PAUL L | See Remarks | D | Stock Option (Right to Buy) | 955864 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 13, 2025 | Neumora Therapeutics, Inc. | $NMRA | BERNS PAUL L | See Remarks | A | Stock Option (Right to Buy) | 2000000 | $0.00 | 2,000,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 13, 2025 | Neumora Therapeutics, Inc. | $NMRA | BERNS PAUL L | See Remarks | A | Stock Option (Right to Buy) | 497049 | $0.00 | 497,049.0000 | 0 | 9999.99% | 0.00% |
| Feb. 13, 2025 | Neumora Therapeutics, Inc. | $NMRA | BERNS PAUL L | See Remarks | D | Stock Option (Right to Buy) | 342500 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 13, 2025 | Neumora Therapeutics, Inc. | $NMRA | BERNS PAUL L | See Remarks | D | Stock Option (Right to Buy) | 497049 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 13, 2025 | Neumora Therapeutics, Inc. | $NMRA | BERNS PAUL L | See Remarks | A | Stock Option (Right to Buy) | 342500 | $0.00 | 342,500.0000 | 0 | 9999.99% | 0.00% |
| Feb. 13, 2025 | Neumora Therapeutics, Inc. | $NMRA | BERNS PAUL L | See Remarks | A | Stock Option (Right to Buy) | 955864 | $0.00 | 955,864.0000 | 0 | 9999.99% | 0.00% |
| Feb. 3, 2025 | Metsera, Inc. | $MTSR | BERNS PAUL L | Not found | C | Common Stock | 7523682 | $0.00 | 8,481,241.0000 | 0 | 785.71% | 0.00% |
| Feb. 3, 2025 | Metsera, Inc. | $MTSR | BERNS PAUL L | Not found | P | Common Stock | 789998 | $18.00 | 9,271,239.0000 | 0 | 9.31% | 0.00% |
| Feb. 3, 2025 | Metsera, Inc. | $MTSR | BERNS PAUL L | Not found | C | Series A Convertible Preferred Stock | 15000000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 3, 2025 | Metsera, Inc. | $MTSR | BERNS PAUL L | Not found | C | Series B Convertible Preferred Stock | 2678571 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Dec. 27, 2024 | Neumora Therapeutics, Inc. | $NMRA | BERNS PAUL L | Not found | G | Common Stock | 133097 | $0.00 | 7,951,263.0000 | 0 | 1.65% | 0.00% |
| Dec. 27, 2024 | Neumora Therapeutics, Inc. | $NMRA | BERNS PAUL L | Not found | G | Common Stock | 133097 | $0.00 | 7,818,166.0000 | 0 | 1.67% | 0.00% |
| Dec. 27, 2024 | Neumora Therapeutics, Inc. | $NMRA | BERNS PAUL L | Not found | G | Common Stock | 133097 | $0.00 | 8,084,360.0000 | 0 | 1.62% | 0.00% |
| June 21, 2024 | Unity Biotechnology, Inc. | $UNBX | BERNS PAUL L | Not found | A | Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 14, 2024 | Neumora Therapeutics, Inc. | $NMRA | BERNS PAUL L | Not found | A | Stock Option (Right to Buy) | 342500 | $0.00 | 342,500.0000 | 0 | 9999.99% | 0.00% |
| Feb. 14, 2024 | Neumora Therapeutics, Inc. | $NMRA | BERNS PAUL L | Not found | A | Common Stock | 171250 | $0.00 | 7,818,166.0000 | 0 | 2.24% | 0.00% |